Healthcare Realty Narrows Losses Amid Asset Sales, Declining Rental Income

TL;DR

**HR is shedding assets and still bleeding cash, making it a risky bet despite narrowing losses.**

AI Summary

Healthcare Realty Trust Inc. (HR) reported a significant net loss of $264.076 million for the nine months ended September 30, 2025, a substantial improvement from the $555.692 million net loss in the prior year, primarily due to a lack of goodwill impairment in 2025 compared to $250.530 million in 2024. Rental income decreased to $863.326 million for the nine months ended September 30, 2025, down from $932.710 million in the same period of 2024, reflecting a 7.4% decline. The company's total assets decreased from $10.650 billion at December 31, 2024, to $9.859 billion at September 30, 2025, driven by a reduction in total real estate properties, net, from $9.327 billion to $8.009 billion. However, HR realized a substantial gain on sales of real estate properties and other assets, totaling $99.678 million for the nine months ended September 30, 2025, up from $77.670 million in 2024. Impairment of real estate properties and credit loss reserves increased to $258.791 million in 2025 from $232.450 million in 2024. The company also reduced its notes and bonds payable from $4.662 billion to $4.485 billion, indicating debt management efforts. Cash and cash equivalents declined from $68.916 million to $43.345 million over the nine-month period.

Why It Matters

Healthcare Realty Trust's continued net losses and declining rental income signal ongoing challenges in the medical office building sector, impacting investor returns and potentially limiting future growth. The significant asset sales, while generating gains, also reduce the company's overall property portfolio, which could affect long-term revenue stability and competitive positioning against peers like Ventas or Welltower. Employees might face uncertainty if portfolio adjustments lead to operational restructuring. For customers, a shrinking or less invested property base could impact service quality or availability. The broader market will watch how HR navigates these headwinds, as it could indicate trends for other healthcare REITs facing rising interest rates and property impairments.

Risk Assessment

Risk Level: high — The company reported a net loss of $264.076 million for the nine months ended September 30, 2025, and an increase in impairment of real estate properties and credit loss reserves to $258.791 million. Cash and cash equivalents decreased by $25.419 million, from $68.916 million to $43.345 million, indicating ongoing cash burn from operations and investing activities.

Analyst Insight

Investors should exercise extreme caution and consider divesting or avoiding HR shares given the persistent net losses, declining rental income, and significant asset impairments. Monitor future filings for sustained profitability and positive cash flow from operations before considering any investment.

Financial Highlights

debt To Equity

1.08

revenue

$863,326,000

operating Margin

N/A

total Assets

$9,859,647,000

total Debt

$4,485,706,000

net Income

-$264,076,000

eps

-$0.75

gross Margin

N/A

cash Position

$43,345,000

revenue Growth

-7.4%

Revenue Breakdown

Key Numbers

• $264.076M — Net Loss (Improved from $555.692M in 2024, but still a significant loss for the nine months ended September 30, 2025.)
• $863.326M — Rental Income (Decreased by 7.4% from $932.710M in the prior year, indicating revenue pressure.)
• $99.678M — Gain on Sales of Real Estate (Increased from $77.670M in 2024, suggesting strategic asset divestitures.)
• $258.791M — Impairment of Real Estate (Increased from $232.450M in 2024, highlighting potential asset value deterioration.)
• $4.485B — Notes and Bonds Payable (Reduced from $4.662B at December 31, 2024, showing debt reduction efforts.)
• $43.345M — Cash and Cash Equivalents (Decreased from $68.916M, indicating a reduction in liquidity.)
• 351,628,689 — Common Stock Outstanding (As of October 24, 2025, reflecting the total shares in circulation.)
• $0.17 — Basic Loss Per Share (Q3 2025) (Improved from $0.26 in Q3 2024, but still a loss.)
• $0.75 — Basic Loss Per Share (YTD 2025) (Improved from $1.49 in YTD 2024, but still a loss.)
• 519 — Consolidated Real Estate Properties (As of September 30, 2025, representing the company's core asset base.)

Key Players & Entities

• Healthcare Realty Trust Inc. (company) — Registrant and real estate investment trust
• $264.076 million (dollar_amount) — Net loss for the nine months ended September 30, 2025
• $555.692 million (dollar_amount) — Net loss for the nine months ended September 30, 2024
• $863.326 million (dollar_amount) — Rental income for the nine months ended September 30, 2025
• $932.710 million (dollar_amount) — Rental income for the nine months ended September 30, 2024
• $99.678 million (dollar_amount) — Gain on sales of real estate properties for the nine months ended September 30, 2025
• $258.791 million (dollar_amount) — Impairment of real estate properties for the nine months ended September 30, 2025
• $4.485 billion (dollar_amount) — Notes and bonds payable as of September 30, 2025
• $43.345 million (dollar_amount) — Cash and cash equivalents as of September 30, 2025
• New York Stock Exchange (regulator) — Exchange where Class A Common Stock is registered

FAQ

Risk Factors

• Real Estate Impairment and Credit Losses [high — financial]: Impairment of real estate properties and credit loss reserves increased to $258.791 million for the nine months ended September 30, 2025, up from $232.450 million in the same period of 2024. This indicates potential deterioration in asset values and increased risk of tenant defaults.
• Declining Rental Income [medium — financial]: Rental income decreased by 7.4% to $863.326 million for the nine months ended September 30, 2025, compared to $932.710 million in the prior year. This revenue pressure could impact profitability and cash flow.
• Reduced Liquidity [medium — financial]: Cash and cash equivalents declined from $68.916 million at the start of the period to $43.345 million by September 30, 2025. This reduction in readily available funds could limit the company's ability to meet short-term obligations or pursue new opportunities.
• Asset Divestitures and Portfolio Reduction [medium — financial]: Total assets decreased from $10.650 billion to $9.859 billion, primarily driven by a reduction in total real estate properties, net, from $9.327 billion to $8.009 billion. While this includes gains on sales, it signifies a shrinking asset base.
• Significant Net Loss [high — financial]: Despite an improvement from the prior year, the company reported a net loss of $264.076 million for the nine months ended September 30, 2025. This continued unprofitability poses a long-term risk.
• Goodwill Impairment (Prior Year Impact) [medium — operational]: The significant improvement in net loss for 2025 ($264.076 million) compared to 2024 ($555.692 million) was primarily due to the absence of a $250.530 million goodwill impairment charge in 2025. While positive, it highlights the volatility of past valuations.

Industry Context

Healthcare Realty Trust operates in the healthcare real estate sector, which is influenced by demographic trends, healthcare utilization, and the financial health of healthcare providers. The sector typically benefits from an aging population but faces challenges related to reimbursement rates, regulatory changes, and the increasing demand for specialized facilities.

Regulatory Implications

The healthcare real estate sector is subject to various regulations impacting healthcare providers, which can indirectly affect property occupancy and rental income. Changes in healthcare policy, such as Medicare/Medicaid reimbursement rates or regulations on healthcare facility operations, could pose risks to tenants and, consequently, to HR's rental income and property values.

What Investors Should Do

1. Monitor asset disposition strategy
2. Analyze tenant creditworthiness and lease expirations
3. Evaluate debt management and liquidity
4. Assess the impact of healthcare policy changes

Key Dates

• 2025-09-30: Nine months ended September 30, 2025 — Reporting period for the condensed consolidated financial statements, showing a reduced net loss but declining rental income and assets.
• 2024-12-31: As of December 31, 2024 — Prior year-end balance sheet figures used for comparison, showing higher total assets and debt.
• 2025-10-24: Common Stock Outstanding — Indicates the total number of shares in circulation as of a recent date, relevant for per-share calculations.

Glossary

Goodwill Impairment

An accounting charge that occurs when the fair value of an acquired company (or a reporting unit) is less than its carrying value on the balance sheet. It reflects a permanent decline in value. (The absence of a goodwill impairment charge in 2025 significantly improved the reported net loss compared to 2024.)

Assets Held for Sale

Assets that management has committed to sell, are available for immediate sale in their present condition, and the sale is probable within one year. (The increase in 'Assets held for sale, net' from $12.897 million to $604.747 million suggests a strategic effort to divest properties.)

Lease Intangibles

An intangible asset representing the value of favorable lease terms acquired in a business combination or property acquisition. (A decrease in lease intangibles from $664.867 million to $504.309 million is consistent with the overall reduction in real estate properties.)

Investment in Financing Receivable, Net

Represents loans or receivables related to financing arrangements, net of any allowances for credit losses. (This line item shows a relatively stable balance, indicating consistent financing activities or a stable portfolio of these receivables.)

Non-Controlling Interest

The portion of equity in a subsidiary that is not attributable to the parent company. It represents the ownership interest of outside shareholders. (Changes in non-controlling interest can reflect shifts in ownership of consolidated joint ventures or subsidiaries.)

Cumulative Dividends

The total amount of dividends paid out to shareholders over time. (The significant increase in cumulative dividends paid reflects the company's historical dividend policy, even amidst current losses.)

Year-Over-Year Comparison

For the nine months ended September 30, 2025, Healthcare Realty Trust Inc. reported a net loss of $264.076 million, a significant improvement from $555.692 million in the prior year, largely due to the absence of a substantial goodwill impairment charge. However, rental income decreased by 7.4% to $863.326 million, and total assets and real estate properties, net, also declined. While gains on sales of real estate increased, impairment charges and credit loss reserves rose, indicating ongoing asset value concerns and reduced liquidity as cash and cash equivalents fell.

Key Financial Figures

• $0.01 — Which Registered Class A Common Stock, $0.01 par value per share HR New York Stock E

Filing Documents

• hr-20250930.htm (10-Q) — 1767KB
• hr-2025930xex22.htm (EX-22) — 5KB
• hr-2025930xex311.htm (EX-31.1) — 11KB
• hr-2025930xex312.htm (EX-31.2) — 11KB
• hr-2025930xex32.htm (EX-32) — 7KB
• 0001360604-25-000112.txt ( ) — 10227KB
• hr-20250930.xsd (EX-101.SCH) — 70KB
• hr-20250930_cal.xml (EX-101.CAL) — 113KB
• hr-20250930_def.xml (EX-101.DEF) — 329KB
• hr-20250930_lab.xml (EX-101.LAB) — 853KB
• hr-20250930_pre.xml (EX-101.PRE) — 581KB
• hr-20250930_htm.xml (XML) — 1685KB

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION Item 1

Financial Statements

Financial Statements 1 Condensed Consolidated Balance Sheets 1 Condensed Consolidated Statements of Operations 2 Condensed Consolidated Statements of Comprehensive Loss 3 Condensed Consolidated Statements of Equity and Redeemable Non-Controlling Interests 4 Condensed Consolidated Statements of Cash Flows 6 Notes to the Condensed Consolidated Financial Statements 8 Item 2

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 27 Item 3

Quantitative and Qualitative Disclosures about Market Risk

Quantitative and Qualitative Disclosures about Market Risk 41 Item 4

Controls and Procedures

Controls and Procedures 41

- OTHER INFORMATION

PART II - OTHER INFORMATION Item 1

Legal Proceedings

Legal Proceedings 42 Item 1A

Risk Factors

Risk Factors 42 Item 2 Unregistered Sales of Equity Securities and Use of Proceeds 42

Other Information 42

Item 5 Other Information 42 Item 6 Exhibits 43 SIGNATURE 44 Table of Contents

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements Healthcare Realty Trust Incorporated Condensed Consolidated Balance Sheets Amounts in thousands, except per share data ASSETS Unaudited SEPTEMBER 30, 2025 DECEMBER 31, 2024 Real estate properties Land $ 1,066,616 $ 1,143,468 Buildings and improvements 8,557,270 9,707,066 Lease intangibles 504,309 664,867 Personal property 6,854 9,909 Investment in financing receivable, net 123,346 123,671 Financing lease right-of-use assets 75,462 77,343 Construction in progress — 31,978 Land held for development 57,203 52,408 Total real estate properties 10,391,060 11,810,710 Less accumulated depreciation and amortization ( 2,381,297 ) ( 2,483,656 ) Total real estate properties, net 8,009,763 9,327,054 Cash and cash equivalents 43,345 68,916 Assets held for sale, net 604,747 12,897 Operating lease right-of-use assets 209,291 261,438 Investments in unconsolidated joint ventures 458,627 473,122 Other assets, net 533,874 507,496 Total assets $ 9,859,647 $ 10,650,923 LIABILITIES, REDEEMABLE NON-CONTROLLING INTERESTS, AND STOCKHOLDERS' EQUITY Liabilities Notes and bonds payable $ 4,485,706 $ 4,662,771 Accounts payable and accrued liabilities 173,784 222,510 Liabilities of assets held for sale 69,808 1,283 Operating lease liabilities 166,231 224,499 Financing lease liabilities 72,654 72,346 Other liabilities 146,618 161,640 Total liabilities 5,114,801 5,345,049 Commitments and contingencies Redeemable non-controlling interests 4,332 4,778 Stockholders' equity Preferred stock, $ .01 par value per share; 200,000 shares authorized; none issued and outstanding — — Class A Common stock, $ .01 par value per share; 1,000,000 shares authorized; 351,604 and 350,532 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively 3,516 3,505 Additional paid-in capital 9,134,486 9,118,229 Accumulated other comprehensive loss ( 6,461 ) ( 1,168 ) Cumulative net income attributable to common stockholder

View Full Filing

View this 10-Q filing on SEC EDGAR